logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
11/3/2017 2:08:26 PM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q1 18 Estimate To -2.08 From -1.87
11/3/2017 2:07:50 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) FY17 Estimate To -4.55 From -7.23
11/3/2017 2:04:46 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q4 17 Estimate To 0.67 From -1.98
11/2/2017 4:13:48 PM Ultragenyx Pharma Q3 Loss Per Share $1.87 Vs Loss $1.64 Last Year
11/1/2017 8:31:47 AM Ultragenyx, Kyowa Hakko Kirin Announce FDA Not Now Planning To Hold Advisory Committee Meeting For Burosumab BLA
10/26/2017 8:42:46 AM Ultragenyx Reports Expiration Of HSR Waiting Period For Acquisition Of Dimension
10/10/2017 8:32:51 AM Ultragenyx And Kyowa Hakko Kirin Announce FDA Acceptance And Priority Review Designation Of Burosumab’s BLA
10/3/2017 8:33:05 AM Ultragenyx Enters Into Definitive Agreement To Acquire Dimension For $6/Shr Cash
10/2/2017 9:25:11 AM Ultragenyx Comments On Dimension’ Announcement That Ultragenyx’s Offer Superior Proposal
10/2/2017 8:12:58 AM Dimension Board Determines Ultragenyx’s Proposal To Buy Dimension For $6.00/shr Constitutes Superior Proposal
9/18/2017 8:35:59 AM Ultragenyx Proposes To Acquire Dimension Therapeutics For $5.50/Shr
9/14/2017 6:46:02 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -5.96 From -5.88
9/14/2017 6:45:46 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 4Q18 Estimate To -1.78 From -1.77